SLC16A4 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-93899
Key Product Details
Species Reactivity
Human, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 388-487 of human SLC16A4 (NP_004687.1). TFPLLMTYTICFAIFAGGYLALILPVLVDLCRNSTVNRFLGLASFFAGMAVLSGPPIAGWLYDYTQTYNGSFYFSGICYLLSSVSFFFVPLAERWKNSLT
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SLC16A4 Antibody - BSA Free
Western Blot: SLC16A4 AntibodyBSA Free [NBP2-93899]
Western Blot: SLC16A4 Antibody [NBP2-93899] - Western blot analysis of extracts of SW480 cells, using SLC16A4 Rabbit pAb (NBP2-93899) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.Applications for SLC16A4 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1:500 - 1:2000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.3), 50% glycerol
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SLC16A4
Long Name
Solute Carrier Family 16 Member 4
Alternate Names
MCT5
Gene Symbol
SLC16A4
Additional SLC16A4 Products
Product Documents for SLC16A4 Antibody - BSA Free
Product Specific Notices for SLC16A4 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...